DK1115380T3 - Mikroniserede farmaceutiske præparater - Google Patents

Mikroniserede farmaceutiske præparater

Info

Publication number
DK1115380T3
DK1115380T3 DK99949133T DK99949133T DK1115380T3 DK 1115380 T3 DK1115380 T3 DK 1115380T3 DK 99949133 T DK99949133 T DK 99949133T DK 99949133 T DK99949133 T DK 99949133T DK 1115380 T3 DK1115380 T3 DK 1115380T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
micronized pharmaceutical
micronised
pharmaceutical compositions
micronized
Prior art date
Application number
DK99949133T
Other languages
English (en)
Other versions
DK1115380T4 (da
Inventor
Richard Anthony Flynn
Martin Harris Goldman
James Richard Lovely
Original Assignee
Pharmax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10839350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1115380(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmax Ltd filed Critical Pharmax Ltd
Publication of DK1115380T3 publication Critical patent/DK1115380T3/da
Application granted granted Critical
Publication of DK1115380T4 publication Critical patent/DK1115380T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99949133T 1998-09-23 1999-09-22 Mikroniserede farmaceutiske præparater DK1115380T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9820746.7A GB9820746D0 (en) 1998-09-23 1998-09-23 Micronised pharmaceutical compositions
PCT/GB1999/003172 WO2000016745A2 (en) 1998-09-23 1999-09-22 Micronised pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DK1115380T3 true DK1115380T3 (da) 2004-10-04
DK1115380T4 DK1115380T4 (da) 2008-06-16

Family

ID=10839350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99949133T DK1115380T4 (da) 1998-09-23 1999-09-22 Mikroniserede farmaceutiske præparater

Country Status (20)

Country Link
EP (1) EP1115380B2 (da)
JP (1) JP5165168B2 (da)
CN (1) CN1148168C (da)
AT (1) ATE267585T1 (da)
AU (1) AU752266B2 (da)
BR (2) BR9914031B1 (da)
CA (1) CA2341366C (da)
CZ (1) CZ298603B6 (da)
DE (1) DE69917658T3 (da)
DK (1) DK1115380T4 (da)
EA (1) EA003193B1 (da)
ES (1) ES2222733T5 (da)
GB (1) GB9820746D0 (da)
HU (1) HU228888B1 (da)
IL (1) IL141913A0 (da)
MX (1) MXPA01003103A (da)
NZ (1) NZ509881A (da)
PL (1) PL197871B1 (da)
PT (1) PT1115380E (da)
WO (1) WO2000016745A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129705A1 (en) * 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
EP1691782A1 (en) * 2003-12-03 2006-08-23 Microdrug AG Medical product containing tiotropium
WO2012061902A1 (en) * 2010-11-12 2012-05-18 Monash University Micronised spray-dried particles comprising polymyxin
MX2015012931A (es) * 2013-03-13 2016-07-20 Forest Lab Holdings Ltd Composiciones farmaceuticas micronizadas.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods
IT1228459B (it) † 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8911259D0 (en) † 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
US5916596A (en) † 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US5875776A (en) † 1996-04-09 1999-03-02 Vivorx Pharmaceuticals, Inc. Dry powder inhaler
WO1998020836A2 (en) * 1996-11-15 1998-05-22 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections

Also Published As

Publication number Publication date
JP5165168B2 (ja) 2013-03-21
EA003193B1 (ru) 2003-02-27
WO2000016745A2 (en) 2000-03-30
CZ298603B6 (cs) 2007-11-21
EA200100253A1 (ru) 2001-08-27
HU228888B1 (en) 2013-06-28
AU6212299A (en) 2000-04-10
EP1115380B1 (en) 2004-05-26
DK1115380T4 (da) 2008-06-16
JP2002526435A (ja) 2002-08-20
BRPI9914031B8 (pt) 2019-02-26
PL346774A1 (en) 2002-02-25
ES2222733T3 (es) 2005-02-01
MXPA01003103A (es) 2005-02-17
IL141913A0 (en) 2002-03-10
CN1148168C (zh) 2004-05-05
ATE267585T1 (de) 2004-06-15
AU752266B2 (en) 2002-09-12
BR9914031B1 (pt) 2011-02-08
CA2341366A1 (en) 2000-03-30
CN1321082A (zh) 2001-11-07
PL197871B1 (pl) 2008-05-30
NZ509881A (en) 2003-01-31
ES2222733T5 (es) 2008-06-16
HUP0104928A3 (en) 2002-08-28
PT1115380E (pt) 2004-10-29
EP1115380B2 (en) 2008-03-12
CA2341366C (en) 2008-11-18
BR9914031A (pt) 2001-06-19
DE69917658T3 (de) 2009-04-02
EP1115380A2 (en) 2001-07-18
GB9820746D0 (en) 1998-11-18
WO2000016745A3 (en) 2001-05-10
DE69917658T2 (de) 2005-06-09
DE69917658D1 (de) 2004-07-01
CZ20011050A3 (cs) 2001-09-12
HUP0104928A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
MY126253A (en) Capsules for inhalation
GR3004448T3 (da)
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
IL90435A (en) 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
BR9912748A (pt) Cápsula em duas partes para receber preparações farmacêuticas para inaladores de pó
FI970164A0 (fi) Inhalaatioformula
TNSN05046A1 (en) Method of preparing dry powder inhalation compositions
YU38802A (sh) Nova kompozicija i njena upotreba
AU1811688A (en) Solid drug preparations containing micronized crystals of ebselen
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
NZ336592A (en) Formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml comprising finely divided budesonide and a carrier
TW200505436A (en) Modified release pharmaceutical compositions and the processes for preparing them
DK1115380T3 (da) Mikroniserede farmaceutiske præparater
GB2021409A (en) Pharmaceutical composition
GEP20043377B (en) Pharmaceutical Complex
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
BG104452A (en) New derivatives of the methylenebisphosphonic acid
IL97509A0 (en) Lipid lowering compositions comprising bambuterol
GB1446237A (en) Pharmaceutical preparations containing pyrazolones
NO924145D0 (no) Sammensetning for faste, farmasoeytiske preparater inneholdende vitamin d3-derivat, og fremgangsmaate for fremstilling derav
IT1259140B (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina
IL103676A0 (en) Pharmaceutical compositions containing hemoglobins as drug delivery agents and methods for the preparation thereof